Tilray Brands (TLRY) Capital Expenditures (2017 - 2025)
Tilray Brands (TLRY) reported Capital Expenditures of $6.3 million for Q2 2025, down 34.8% on a YoY basis from $9.7 million in Q2 2024, and down 56.08% quarter-over-quarter from $14.4 million in Q1 2025.
Tilray Brands (TLRY) Capital Expenditures (2017 - 2025) Analysis & Trends
Tilray Brands has reported Capital Expenditures for 9 years, with the latest figure at $6.3 million in Q2 2025.
- For the quarter ending Q2 2025, Capital Expenditures fell 34.8% year-over-year to $6.3 million; the trailing twelve-month figure through May 2025 stood at $32.9 million (up 12.54% YoY), and the FY2025 full-year result was $32.9 million, up 12.54% from the prior year.
- Capital Expenditures for Q2 2025 stood at $6.3 million, down from $14.4 million in the prior quarter.
- The five-year high for Capital Expenditures was $16.3 million in Q3 2021, with the low at $857000.0 in Q1 2023.
- Historically, Capital Expenditures has averaged $7.2 million across 5 years, with a median of $5.9 million in 2023.
- Annual changes were most pronounced in 2021 — Capital Expenditures slumped 89.78% — and 2024, when it soared 1011.79%.
- Tilray Brands' Capital Expenditures stood at $7.5 million in 2021, then sank by 39.83% to $4.5 million in 2022, then grew by 29.14% to $5.9 million in 2023, then dropped by 7.22% to $5.4 million in 2024, then grew by 16.46% to $6.3 million in 2025.
- The last three Capital Expenditures figures came in at $6.3 million (Q2 2025), $14.4 million (Q1 2025), and $5.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 6.33 Mn |
| May 31, 2025 | 6.33 Mn |
| Feb 28, 2025 | 14.41 Mn |
| Feb 28, 2025 | 14.41 Mn |
| Nov 30, 2024 | 5.44 Mn |
| Nov 30, 2024 | 5.44 Mn |
| Aug 31, 2024 | 6.74 Mn |
| Aug 31, 2024 | 6.74 Mn |
| May 31, 2024 | 9.71 Mn |
| May 31, 2024 | 9.71 Mn |
| Feb 29, 2024 | 9.53 Mn |
| Feb 29, 2024 | 9.53 Mn |
| Nov 30, 2023 | 5.86 Mn |
| Nov 30, 2023 | 5.86 Mn |
| Aug 31, 2023 | 4.15 Mn |
| Aug 31, 2023 | 4.15 Mn |
| May 31, 2023 | 12.41 Mn |
| May 31, 2023 | 12.41 Mn |
| Feb 28, 2023 | 857,000.00 |
| Feb 28, 2023 | 857,000.00 |